At close: 3:22:33 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
20,340.0000
36,893.0000
85,227.0000
38,295.0000
Total Liabilities Net Minority Interest
1,699.0000
2,920.0000
4,904.0000
9,014.0000
Total Equity Gross Minority Interest
18,641.0000
33,973.0000
80,323.0000
29,281.0000
Total Capitalization
18,641.0000
33,973.0000
80,323.0000
29,281.0000
Common Stock Equity
18,641.0000
33,973.0000
80,323.0000
29,281.0000
Net Tangible Assets
11,791.0000
27,123.0000
50,305.0000
7,229.0000
Working Capital
11,791.0000
27,123.0000
47,228.0000
6,498.0000
Invested Capital
18,641.0000
33,973.0000
80,323.0000
29,281.0000
Tangible Book Value
11,791.0000
27,123.0000
50,305.0000
7,229.0000
Share Issued
11,713.2440
11,713.2440
11,713.2440
7,274.7670
Ordinary Shares Number
11,713.2440
11,713.2440
11,713.2440
7,274.7670
12/31/2020 - 2/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACTI.ST Active Biotech AB (publ)
0.1084
-0.18%
STABL.ST Stayble Therapeutics AB (publ)
0.5200
+11.59%
ALZ.ST Alzinova AB (publ)
3.4800
+4.82%
ISOFOL.ST Isofol Medical AB (publ)
2.1800
-5.01%
DMYD-B.ST Diamyd Medical AB (publ)
16.60
-3.38%
PILA.ST Pila Pharma AB (publ)
3.8400
+4.63%
HNSA.ST Hansa Biopharma AB (publ)
39.48
-2.52%
ACHL Achilles Therapeutics plc
1.1300
0.00%
VRTX Vertex Pharmaceuticals Incorporated
401.61
-1.75%